antipsychotic agent
remoxipride
(S)-(-)-3-bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxybenz amide
associated with
aplastic anemia
remoxipride
pyrrolidine ring
metabolites
aromatic ring
metabolites
parent compound
induce
apoptosis
HL60 cells
human
bone marrow progenitor
Cells
treated
compound
Apoptosis
assessed
fluorescence microscopy
Hoechst
propidium iodide
cell samples
determination
internucleosomal DNA fragmentation
gel electrophoresis
HL60 cell
terminal deoxynucleotidyl transferase assay
HBMP cells
catechol
hydroquinone
metabolites
NCQ436
NCQ344
induced
apoptosis
HL60
HBMP cells
time-
concentration
dependent
phenols
NCR181
FLA873
FLA797
derivatives
oxidation
pyrrolidine ring
FLA838
NCM001
NCL118
no effect
No
necrosis
cells
treated with
NCQ436
NCQ344
biphasic
effect
cell types
inducing
apoptosis
concentrations
necrosis
higher
concentrations
data
catechol
hydroquinone
metabolites
remoxipride
toxic effects
HL60
HBMP cells
apoptosis
phenol
metabolites
inactive
catechol
hydroquinone
phenol
induce
apoptosis
HBMP cells
Moran
remoxipride
benzene
induce
aplastic anemia
production
reactive metabolites
NCQ436
NCQ344
induce
apoptosis
HBMP cells
mechanism
aplastic anemia
associated with
remoxipride
